North America Point-of-Care (POC) Drug Abuse Testing Market to 2032
Overview
The North America Point-of-Care (POC) Drug Abuse Testing Market is expected to reach a 843.23 USD Million by 2032 and is projected to grow at a CAGR of 5.54% from 2025 to 2032.
Revenue, 2024 (USD Million)
578.01
Forecast, 2032 (USD Million)
843.23
CAGR, 2024 - 2032
5.54%
Report Coverage
North America
North America Point-of-Care (POC) Drug Abuse Testing Market 2018-2032 USD Million
North America Point-of-Care (POC) Drug Abuse Testing Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 578.01 USD Million
- Projected Market Size (2032): 843.23 USD Million
- CAGR (2025-2032): 5.54%
Key Findings of North America Point-of-Care (POC) Drug Abuse Testing Market
- The North America Point-of-Care (POC) Drug Abuse Testing Market was valued at 578.01 USD Million in 2024.
- The North America Point-of-Care (POC) Drug Abuse Testing Market is likely to grow at a CAGR of 5.54% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Testing Type in Prescription Segment accounted for the largest share of the market with a revenue of 578.01 USD Million
- The fastest growing segment Amphetamines in Drug Type Segment grew Fastest with a CAGR of 8.87% during the forecast period from 2024 to 2032.
North America Point-of-Care (POC) Drug Abuse Testing Market Scope
North America Point-of-Care (POC) Drug Abuse Testing Market Segmentation & Scope
Drug Type
- Others
- Tricyclic Antidepressants
- Phencyclidine
- Methadone
- Benzodiazepines
- Barbiturates
- Cocaine
- Cannabinoids
- Opiates
- Amphetamines
Products
- Consumables and Accessories
- Devices
Prescription
- Prescription-Based Testing
- Over the Counter Testing
- Testing Type
- Sample Type
- Application
- End User
Distribution Channel
- Others
- Retail Sales
- Direct Tender
North America Point-of-Care (POC) Drug Abuse Testing Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2023 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 578.01 USD Million |
| Market Value in 2032 | 843.23 USD Million |
| CAGR (2025-2032) | 5.54% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Drug Type,Products,Prescription,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): North America, leading in terms of revenue 578.01 USD Million in 2024
- Key Country: U.S., leading in terms of revenue with value of 511.24 USD Million in 2024.
Segments and Scope
-
North America Point-of-Care (POC) Drug Abuse Testing Market to 2032, By Drug Type
- Amphetamines is the largest segment in North America Point-of-Care (POC) Drug Abuse Testing Market to 2032 with a revenue of 109.27 USD Million in the year 2024.
- Amphetamines is the Fastest growing segment in North America Point-of-Care (POC) Drug Abuse Testing Market to 2032 with a Growth rate of 8.87 % in forecast period 2025-2032.
-
North America Point-of-Care (POC) Drug Abuse Testing Market to 2032, By Products
- Devices is the largest segment in North America Point-of-Care (POC) Drug Abuse Testing Market to 2032 with a revenue of 365.23 USD Million in the year 2024.
- Consumables and Accessories is the Fastest growing segment in North America Point-of-Care (POC) Drug Abuse Testing Market to 2032 with a Growth rate of 5.31 % in forecast period 2025-2032.
-
North America Point-of-Care (POC) Drug Abuse Testing Market to 2032, By Prescription
- Testing Type is the largest segment in North America Point-of-Care (POC) Drug Abuse Testing Market to 2032 with a revenue of 578.01 USD Million in the year 2024.
- Over the Counter Testing is the Fastest growing segment in North America Point-of-Care (POC) Drug Abuse Testing Market to 2032 with a Growth rate of 5.54 % in forecast period 2025-2032.
-
North America Point-of-Care (POC) Drug Abuse Testing Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in North America Point-of-Care (POC) Drug Abuse Testing Market to 2032 with a revenue of 339.93 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in North America Point-of-Care (POC) Drug Abuse Testing Market to 2032 with a Growth rate of 5.68 % in forecast period 2025-2032.
North America Point-of-Care (POC) Drug Abuse Testing Market Company Share Analysis
| Company Name |
|
||
| Thermo Fisher Scientific Inc. | |||
| Quest Diagnostics Incorporated | |||
| Abbott | |||
| F. Hoffmann-La Roche Ltd. | |||
| Siemens Healthcare GmbH | |||
North America Point-of-Care (POC) Drug Abuse Testing Market Geographical Sales Distribution, 2018-2032 USD Million
North America Point-of-Care (POC) Drug Abuse Testing Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The North America Point-of-Care (POC) Drug Abuse Testing Market is segmented based on Segmentation Drug Type,Products,Prescription,Distribution Channel.
North America Point-of-Care (POC) Drug Abuse Testing Market was valued at USD 578.01(Revenue in USD Million) in 2023.
North America Point-of-Care (POC) Drug Abuse Testing Market is projected to grow at a CAGR of 5.54% during the forecast period of 2024 to 2032.
The Testing Type segment is expected to dominate the North America Point-of-Care (POC) Drug Abuse Testing Market, holding a largest market share of 578.01 USD Million in 2024
North America Point-of-Care (POC) Drug Abuse Testing Market Scope
North America Point-of-Care (POC) Drug Abuse Testing Market Segmentation & Scope
Drug Type
- Others
- Tricyclic Antidepressants
- Phencyclidine
- Methadone
- Benzodiazepines
- Barbiturates
- Cocaine
- Cannabinoids
- Opiates
- Amphetamines
Products
- Consumables and Accessories
- Devices
Prescription
- Prescription-Based Testing
- Over the Counter Testing
- Testing Type
- Sample Type
- Application
- End User
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Frequently Asked Questions
The North America Point-of-Care (POC) Drug Abuse Testing Market is segmented based on Segmentation Drug Type,Products,Prescription,Distribution Channel.
North America Point-of-Care (POC) Drug Abuse Testing Market was valued at USD 578.01(Revenue in USD Million) in 2023.
North America Point-of-Care (POC) Drug Abuse Testing Market is projected to grow at a CAGR of 5.54% during the forecast period of 2024 to 2032.
The estimated market value of the North America Point-of-Care (POC) Drug Abuse Testing Market for final year is USD 843.23 (USD Million).
North America Point-of-Care (POC) Drug Abuse Testing Market Company Profiling
Frequently Asked Questions
The North America Point-of-Care (POC) Drug Abuse Testing Market is segmented based on Segmentation Drug Type,Products,Prescription,Distribution Channel.
North America Point-of-Care (POC) Drug Abuse Testing Market was valued at USD 578.01(Revenue in USD Million) in 2023.
North America Point-of-Care (POC) Drug Abuse Testing Market is projected to grow at a CAGR of 5.54% during the forecast period of 2024 to 2032.
The estimated market value of the North America Point-of-Care (POC) Drug Abuse Testing Market for final year is USD 843.23 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.